i-Base home
Search Menu
  • Home
  • HTB
  • 2024
  • November

November 2024

Contents

Special reports

  • Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan

Conference reports

  • Glasgow HIV Congress 2024: Introduction and links
  • Once-weekly oral ART with islatravir plus lenacapavir sustains results to week 48
  • EACS guidelines: New format and contents includes chemsex
  • Double dose start for oral PrEP in new EACS guidelines – rapid protection in two hours
  • Future PrEP and new results on lenacapavir from PURPOSE 1 and 2 – does HIV exposure explain incident cases?
  • Liverpool University Drug Interaction website recognised for global impact on research and care
  • HCV coinfection approaches zero in Spain: but cirrhosis and reinfection among gay men are still significant even with high rates of cure
  • Dolutegravir/lamivudine vs triple ART have similar efficacy in advanced HIV infection with CD4 <200 and viral load >100,000

Treatment access

  • Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic

mpox

  • Mpox breakthrough cases after two doses of the MVA-BN vaccine

Coinfections and complications

  • Bipolar disorder in people living with HIV

On the web

  • WHO toolkit to strengthen engagement of health workers in emergency responses
  • HTB RSS

Early access

  • Vaccination effectively limits mpox progression: lower efficacy in people living with HIV 27 May 2025
  • US update guidelines for statin use in people living with HIV 26 May 2025
  • HIV activists in the US call for action and Zachie Achmet brings South African perspective 26 May 2025
  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook